Association between red cell distribution width/serum albumin ratio and Parkinson's disease
- PMID: 40448230
- PMCID: PMC12125946
- DOI: 10.1186/s40001-025-02707-z
Association between red cell distribution width/serum albumin ratio and Parkinson's disease
Abstract
Background: The ratio between erythrocyte distribution width and serum albumin (RAR) has gained recognition as a novel composite biomarker for inflammatory processes, though its clinical significance in Parkinson's disease (PD) pathology requires further exploration. The purpose of this cross-sectional study was to investigate the relationship between RAR and PD.
Methods: This epidemiologic investigation utilized data from participants enrolled in the National Health and Nutrition Examination Survey (NHANES) spanning 2003-2018. Study cohorts comprised PD-diagnosed individuals and matched controls. To elucidate the RAR-PD connection, we implemented three analytical strategies: multivariable-adjusted logistic regression models incorporating sample weights, restricted cubic spline (RCS) modeling for nonlinear relationships, and stratified analyses across demographic subgroups. Comparative assessment of inflammatory biomarkers' discriminative performance was performed through ROC curve analysis, contrasting RAR against platelet-albumin ratio (PAR) and neutrophil-albumin ratio (NAR).
Results: The analysis encompassed 31,848 adults (297 PD cases; 31,551 controls) from the NHANES database. Quantitative analysis revealed elevated RAR measurements in PD subjects compared to controls [3.28 (0.04) vs. 3.09 (0.01), P < 0.001]. Following covariate adjustment in weighted regression models, multivariable-adjusted analyses identified RAR as an independent predictor (adjusted OR = 1.40, 95% CI 1.06-1.85, P = 0.018). RCS modeling revealed nonlinear RAR-PD associations, peaking at 3.48 (inverted U-shape). Comparative ROC analysis confirmed RAR's discriminative superiority over PAR and NAR in PD detection (P < 0.05).
Conclusions: As demonstrated by the research findings, RAR is strongly and independently associated with PD. RAR may serve as an indicator or screening tool for an increased risk of PD.
Keywords: Albumin; Cross-sectional study; NHANES; Parkinson's disease; Red cell distribution width.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The NHANES obtained approval from the National Centre for Health Statistics. Research ethics review board and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Red cell distribution width/albumin ratio as a marker for metabolic syndrome: findings from a cross-sectional study.BMC Endocr Disord. 2024 Oct 25;24(1):227. doi: 10.1186/s12902-024-01762-7. BMC Endocr Disord. 2024. PMID: 39455980 Free PMC article.
-
The association between red blood cell distribution width-to-albumin ratio and chest pain prevalence in US adults: A cross-sectional analysis of NHANES 2005-2018.Medicine (Baltimore). 2025 Jul 4;104(27):e43200. doi: 10.1097/MD.0000000000043200. Medicine (Baltimore). 2025. PMID: 40629632 Free PMC article.
-
Association of overactive bladder with red cell distribution width to albumin ratio in American.Sci Rep. 2025 Jul 28;15(1):27395. doi: 10.1038/s41598-025-13129-6. Sci Rep. 2025. PMID: 40721625 Free PMC article.
-
Interventions for preventing falls in Parkinson's disease.Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD011574. doi: 10.1002/14651858.CD011574.pub2. Cochrane Database Syst Rev. 2022. PMID: 35665915 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet. 2021;397(10291):2284–303. - PubMed
-
- Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson’s disease. Lancet. 2024;403(10423):293–304. - PubMed
-
- He Q, Ji L, Wang Y, Zhang Y, Wang H, Wang J, et al. Acetate enables metabolic fitness and cognitive performance during sleep disruption. Cell Metab. 2024;36(9):1998-2014.e15. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials